1. HBW Insight
  3. >>Europe

Alternative Smoking Cessation Drug Cytisine On 2023 German Switch Committee Agenda

 
• By David Ridley

Low-cost alternative smoking cessation drug cytisine is under consideration by Germany's independent switch committee in January, alongside azelastine and fluticasone propionate in combination for intranasal use, olopatadine for ophthalmic use and bilastine (10mg) for oral use.

Natural nicotine replacement drug cytisine is up for Rx-to-OTC switch consideration at the next meeting of the German independent Expert Committee on Prescription, SVA, which takes place in January 2023.

A nicotine-like generic alkaloid that occurs naturally in the laburnum plant species, cytisine – which is being proposed at a dose of 1

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography